New drug development model for cardiovascular disease
With cardiovascular diseases (CVDs) accounting for 45 % of all deaths in Europe and costing the EU economy EUR 210 billion a year, it’s necessary to find better and cost-efficient treatments. Unfortunately, only four drugs targeting CVDs have been approved in the last decade. Efforts to accelerate drug development are urgently needed. The EU-funded EMAPS-Cardio project aims to develop a new organ-on-chip platform for growth and maturation of cardiac microtissues for adult-like organotypic models in healthy and diseased states. Also, the increased sensitivity and accuracy of organ-on-chip devices is a needed leap in technology that will accelerate new drug development without the need for animal models.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeRIA-LS - Research and Innovation action Lump Sum